effects [qlco]
tibolone [phsu, strd]
Combined [qlco]
17 beta-Estradiol [horm, phsu, strd]
Norethisterone [horm, phsu, strd]
Acetate [orch, phsu]
C-reactive protein [aapp, imft]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
randomized [resa]
Trial [resa]
C-reactive protein [aapp, imft]
Independent [idcn]
Cardiovascular Diseases [dsyn]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
Oral [spco]
Progestin [horm, phsu, strd]
Combined [qlco]
17beta estradiol [horm, phsu, strd]
C-reactive protein [aapp, imft]
Post-Menopause [orgf]
Women [popg]
Study [mnob]
effects [qlco]
tibolone [phsu, strd]
Steroid [strd]
Estrogenic [horm, orch, phsu]
Androgen [horm, phsu]
Progestagen [horm, phsu, strd]
properties [qlco]
Combination [qlco]
Of [spco]
Norethisterone acetate [horm, phsu, strd]
Serum C reactive protein level [lbpr]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
Methods [inpr]
Post-Menopause [orgf]
Women [popg]
Age [orga]
Range [qnco]
Assigned [ftcn]
Receive [qlco]
tibolone [phsu, strd]
mg% [qnco]
N NOS [aapp, imft]
tibolone 2.5 MG [clnd]
N NOS [aapp, imft]
mg/mg [qnco]
Plus [qlco]
Neta [fngs]
N NOS [aapp, imft]
C-reactive protein [aapp, imft]
Measured [qlco]
baseline [bodm]
months [tmco]
Doses [qnco]
tibolone [phsu, strd]
Norethisterone acetate [horm, phsu, strd]
Increased [qnco]
C-reactive protein [aapp, imft]
Extent [spco]
months [tmco]
Sustained [ftcn]
treatment [ftcn]
Example [cnce]
months [tmco]
treatment [ftcn]
C-reactive protein [aapp, imft]
Increased [qnco]
P NOS [aapp, imft]
P NOS [aapp, imft]
P NOS [aapp, imft]
tibolone [phsu, strd]
mg% [qnco]
tibolone 2.5 MG [clnd]
E2 [gngm]
Neta [fngs]
Conclusions [idcn]
tibolone [phsu, strd]
Norethisterone acetate [horm, phsu, strd]
Serum C reactive protein level [lbpr]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
Extent [spco]
Relationships [qlco]
Induced [ftcn]
Elevated [qlco]
C-reactive protein level [lbpr]
tibolone [phsu, strd]
Norethisterone acetate [horm, phsu, strd]
cardiovascular events [fndg]
